1. Home
  2. LGND vs HTO Comparison

LGND vs HTO Comparison

Compare LGND & HTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • HTO
  • Stock Information
  • Founded
  • LGND 1987
  • HTO 1985
  • Country
  • LGND United States
  • HTO United States
  • Employees
  • LGND 68
  • HTO N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • HTO Water Supply
  • Sector
  • LGND Health Care
  • HTO Utilities
  • Exchange
  • LGND Nasdaq
  • HTO Nasdaq
  • Market Cap
  • LGND 2.2B
  • HTO 1.8B
  • IPO Year
  • LGND 1992
  • HTO N/A
  • Fundamental
  • Price
  • LGND $139.02
  • HTO $50.45
  • Analyst Decision
  • LGND Strong Buy
  • HTO
  • Analyst Count
  • LGND 8
  • HTO 0
  • Target Price
  • LGND $144.71
  • HTO N/A
  • AVG Volume (30 Days)
  • LGND 139.7K
  • HTO 232.7K
  • Earning Date
  • LGND 08-05-2025
  • HTO 07-28-2025
  • Dividend Yield
  • LGND N/A
  • HTO 3.35%
  • EPS Growth
  • LGND N/A
  • HTO 12.16
  • EPS
  • LGND N/A
  • HTO 2.98
  • Revenue
  • LGND $181,488,000.00
  • HTO $766,656,000.00
  • Revenue This Year
  • LGND $18.41
  • HTO $6.23
  • Revenue Next Year
  • LGND $18.87
  • HTO $5.34
  • P/E Ratio
  • LGND N/A
  • HTO $16.83
  • Revenue Growth
  • LGND 53.40
  • HTO 12.34
  • 52 Week Low
  • LGND $81.74
  • HTO $44.91
  • 52 Week High
  • LGND $129.90
  • HTO $62.18
  • Technical
  • Relative Strength Index (RSI)
  • LGND 75.81
  • HTO N/A
  • Support Level
  • LGND $120.68
  • HTO N/A
  • Resistance Level
  • LGND $126.24
  • HTO N/A
  • Average True Range (ATR)
  • LGND 4.48
  • HTO 0.00
  • MACD
  • LGND 1.87
  • HTO 0.00
  • Stochastic Oscillator
  • LGND 96.06
  • HTO 0.00

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About HTO H2O America Common Stock

H2O America is a national investor-owned network of local water and wastewater utilities united by one purpose: delivering clean, high-quality water to the communities it calls home. Across approximately 407,000 water and wastewater service connections, the company invests in critical infrastructure to strengthen the water supply for generations to come.

Share on Social Networks: